[Federal Register Volume 84, Number 34 (Wednesday, February 20, 2019)]
[Notices]
[Pages 5115-5116]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-02721]


=======================================================================
-----------------------------------------------------------------------

NUCLEAR REGULATORY COMMISSION


Advisory Committee on the Medical Uses of Isotopes; Call for 
Nominations

AGENCY: Nuclear Regulatory Commission.

ACTION: Call for nominations.

-----------------------------------------------------------------------

SUMMARY: The U.S. Nuclear Regulatory Commission (NRC) is advertising 
for nominations for the Nuclear Medicine Physician position and the 
Patients' Rights Advocate position on the Advisory Committee on the 
Medical Uses of Isotopes (ACMUI). Nuclear

[[Page 5116]]

Medicine Physician nominees should currently be practicing nuclear 
medicine in a clinical setting. Patients' Rights Advocate nominees 
should have professional or personal experience with or knowledge about 
patient advocacy. Also, involvement or leadership with patient advocacy 
organizations is preferred.

DATES: Nominations are due on or before April 22, 2019.

NOMINATION PROCESS: Submit an electronic copy of resume or curriculum 
vitae, along with a cover letter, to Ms. Kellee Jamerson, 
[email protected]. The cover letter should describe the nominee's 
current involvement with patients' rights advocacy and express the 
nominee's interest in the position. Please ensure that the resume or 
curriculum vitae includes the following information, if applicable: 
education; certification; professional association membership and 
committee membership activities; and number of years, timeframe, and 
type of setting for patient advocacy.

FOR FURTHER INFORMATION CONTACT: Ms. Kellee Jamerson, U.S. Nuclear 
Regulatory Commission, Office of Nuclear Material Safety and 
Safeguards; (301) 415-7408; [email protected].

SUPPLEMENTARY INFORMATION: The ACMUI Nuclear Medicine Physician 
provides advice to the NRC staff on ideas associated with the 
regulation of diagnostic and therapeutic applications of byproduct 
material. This advice includes providing input on the NRC's proposed 
rules and guidance documents; providing recommendations on the training 
and experience requirements for physicians specializing in diagnostic 
and therapeutic nuclear medicine; identifying medical events associated 
with these uses; evaluating non-routine medical uses of byproduct 
material; bringing key issues in the nuclear medicine community to the 
attention of the NRC staff; and other nuclear medicine issues as they 
relate to radiation safety and the NRC Medical-Use Policy Statement.
    The ACMUI Patients' Rights Advocate provides advice to the NRC 
staff on patients' issues associated with the regulation of medical 
applications of byproduct material. This advice includes ensuring 
patients' rights are represented during the development and 
implementation of the NRC's medical-use regulations. This individual is 
appointed based on his or her professional and personal experience with 
and/or knowledge about patient advocacy, as well as involvement and/or 
leadership with patient advocacy organizations.
    ACMUI members are selected based on their educational background, 
certification(s), work experience, involvement and/or leadership in 
professional society activities, and other information obtained in 
letters or during the selection process. Nominees should have the 
demonstrated ability to establish effective work relationships with 
peers and implement successful approaches to problem solving and 
conflict resolution. ACMUI members currently serve a four-year term and 
may be considered for reappointment to an additional term. The current 
ACMUI membership is comprised of the following professionals: (a) 
Nuclear medicine physician; (b) nuclear cardiologist; (c) nuclear 
medicine physicist; (d) therapy medical physicist; (e) radiation safety 
officer; (f) nuclear pharmacist; (g) two radiation oncologists; (h) 
patients' rights advocate; (i) Food and Drug Administration 
representative; (j) Agreement State representative; (k) health care 
administrator; and (l) diagnostic radiologist. For additional 
information about membership on the ACMUI, visit the ACMUI Membership 
web page, http://www.nrc.gov/about-nrc/regulatory/advisory/acmui/membership.html.
    Nominees must be U.S. citizens and be able to devote approximately 
160 hours per year to ACMUI business. Members are expected to attend 
semi-annual meetings in Rockville, Maryland and to participate in 
teleconferences, as needed. Members who are not Federal employees are 
compensated for their service. In addition, members are reimbursed for 
travel (including per diem in lieu of subsistence) and are reimbursed 
secretarial and correspondence expenses. Full-time Federal employees 
are reimbursed for travel expenses only.
    Security Background Check: The selected nominee will undergo a 
thorough security background check. Security paperwork may take the 
nominee several weeks to complete. Nominees will also be required to 
complete a financial disclosure statement to avoid conflicts of 
interest.

    Dated at Rockville, Maryland this 13th day of February, 2019.

    For the Nuclear Regulatory Commission.
Russell E. Chazell,
Federal Advisory Committee Management Officer.
[FR Doc. 2019-02721 Filed 2-19-19; 8:45 am]
 BILLING CODE 7590-01-P